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Correspondence
We appreciated the interest of Barison and colleagues in our 
International Consensus Statement on the treatment of arrhythmo-
genic right ventricular cardiomyopathy/dysplasia (ARVC/D).1 Our 
document provided a comprehensive overview and recommendations 
for risk stratification and therapy of patients fulfilling the diagnostic 
criteria for ARVC/D. These criteria had been addressed by a previous 
International Task Force consensus document dedicated to diagno-
sis of ARVC/D.2 According to the revised criteria proposed by the 
International Task Force in 2010, the diagnosis of ARVC/D is based 
on the presence of major and minor criteria encompassing electrocar-
diographic, arrhythmic, morphological, histopathologic, and genetic 
factors. Diagnosis of definite ARVC/D is fulfilled in the presence of 
2 major criteria or 1 major plus 2 minor or 4 minor criteria from dif-
ferent groups; the ARVC/D diagnosis is possible or borderline in the 
presence of insufficient criteria.
In their Letter to the Editor, Barison and colleagues emphasized 
the valuable role of cardiac magnetic resonance (CMR) for diagno-
sis of ARVC/D, which relies on its ability to combine evaluation of 
ventricular size, function, and regional wall motion with character-
ization by late-gadolinium enhancement (LGE) of fibro-fatty myo-
cardial scar, which is the hallmark lesion of ARVC/D. We totally 
agree that CMR is becoming the gold standard tool for detection of 
structural and functional ventricular abnormalities in ARVC/D. In 
the 2010 International Task Force consensus document, CMR was 
appropriately included among the diagnostic imaging techniques, 
and specific CMR reference values for normal (and abnormal) ven-
tricular size, systolic function, and regional dyssynergy were pro-
vided. Tissue characterization by LGE was not included among these 
diagnostic criteria because of the potential risk of misdiagnosis of 
ARVC/D related to the difficulty of assessing LGE at the level of 
the thin right ventricular wall and possible confusion with normal 
epicardial fat tissue. More recently, the frequent involvement by the 
disease of the left ventricular wall in the form of epicardial-medio-
mural LGE has been recognized. As pointed out by the authors, LV 
LGE may enhance sensitivity for early/minor or predominant left 
variants of the ARVC/D; however, its diagnostic accuracy remains 
to be established.
The prognostic role of CMR and, in particular, of postcontrast 
sequences for tissue characterization in patients with a diagnosis of 
definitive ARVC/D remains elusive. In our consensus statement on 
the treatment of ARVC/D, we performed a systematic review of out-
come studies on ARVC/D available in the literature to identify pre-
dictor variables that were associated with an increased risk of major 
arrhythmic events (ie, sudden cardiac death, appropriate defibrillator 
interventions, or defibrillator therapy on fast ventricular tachycardia/
ventricular fibrillation), nonsudden cardiac death, or heart transplan-
tation in at least 1 published multivariable analysis. Although the 
predicting value of CMR for worse arrhythmic outcome was shown 
in the general population of patients showing premature ventricular 
beats with a left bundle branch morphology4 and in patients with sus-
pected diagnosis of ARVC/D,5 no specific features of CMR, either 
alone or in combination, have been reported yet as independent pre-
dictors of life-threatening arrhythmic events in patients with a definite 
diagnosis of ARVC/D. This lack of evidence underscores the impor-
tance of undertaking future studies on this field.
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